1.Toxifolin inhibits malignant biological behaviors of bladder cancer T24 cells via Rac1/NF-κB/AKT signaling pathway
LU Tong1 ; YUAN Xiaoke2 ; FU Tianying3 ; SHAO Yonggang4 ; LU Yingwen4
Chinese Journal of Cancer Biotherapy 2025;32(6):604-610
[摘 要] 目的:探究花旗松素(TAX)通过Rac1/NF-κB/AKT信号通路调控人膀胱癌T24细胞的恶性生物学行为。方法:常规培养膀胱癌T24细胞,将其分为:Ctrl组(未处理)、TAX-L组(5 μmol/L TAX处理)、TAX-M组(10 μmol/L TAX处理 )、TAX-H组(20 μmol/L TAX处理)、TAX-H + Rac1激活剂组(20 μmol/L TAX + 50 nmol/L ML-097处理)。CCK-8法、克隆形成实验、划痕愈合实验、Transwell小室实验和流式细胞术分别检测不同浓度TAX对T24细胞增殖、迁移、侵袭能力和凋亡的影响,WB法检测对各组T24细胞中细胞凋亡、上皮间充质转化、Rac1/NF-κB/AKT轴相关蛋白表达的影响;T24细胞裸鼠移植瘤实验检测TAX对移植瘤生长的影响。结果:TAX呈剂量依赖性地抑制T24细胞的增殖、迁移和侵袭能力,并促进其凋亡(均P < 0.05),促进凋亡蛋白BAX和E-cadherin、抑制Rac1/NF-κB/AKT信号通路相关蛋白的表达、Bcl-2和N-cadherin蛋白表达(均P < 0.05),抑制移植瘤的生长(P < 0.05),ML-097均可部分逆转上述作用(均P < 0.05)。结论:TAX通过抑制Rac1/NF-κB/AKT信号通路中抑制膀胱癌T24细胞的恶性生物学行为,促进其凋亡。
2.Role of TIM3 Pathway in Immune Pathogenesis and Targeted Therapy of Myelodysplastic Syndrome
Xinyu GUO ; Shunjie YU ; Jinglian TAO ; Yingshuai WANG ; Xiaotong REN ; Zhaoyun LIU ; Rong FU ; Zonghong SHAO ; Lijuan LI
Cancer Research on Prevention and Treatment 2025;52(9):731-735
Myelodysplastic syndrome (MDS), a myeloid tumor derived from the malignant clones of hematopoietic stem cells, has an annually increasing incidence. The contemporary research direction has shifted to analyzing the synergistic effect of immune surveillance collapse and abnormal bone marrow microenvironment in the pathological process of MDS. Against this backdrop, the immune checkpoint molecule TIM3 has emerged as a key target because of its persistently high expression on the surface of important immune cells such as T and NK cells. The abnormal activation of the TIM3 pathway is the mechanism by which solid tumors and hematological malignancies achieve immune escape and is a key hub in the formation of immune exhaustion phenotypes. This work integrates the original discoveries of our team with the latest international progress, systematically demonstrating the bidirectional regulatory network of TIM3 between the malignant clone proliferation of MDS and the immunosuppressive microenvironment. Integrating the evidence from emerging clinical trials allows us to consider the clinical significance of TIM3-targeted blocking for MDS, providing a transformative path to overcome the resistance of traditional treatments and marking a new chapter in the active immune reconstitution of MDS treatment.
3.Application of bioactive ceramics iRoot BP Plus? in pulpotomy for complicated crown fracture of immature permanent anterior teeth in children
Jiajia ZHENG ; Xue YANG ; Quan WEN ; Yuan FU ; Xiao SHAO ; Meili DING
Journal of Peking University(Health Sciences) 2024;56(1):179-184
Objective:To analyze the clinical and radiographic effectiveness of a calcium silicate-based bioactive ceramic iRoot BP Plus? pulpotomy of immature permanent teeth with complicated crown fracture and to evaluate the factors influencing its long-term success rate.Methods:The digital medical records of patients under 13 years old who had undergone iRoot BP Plus? pulpotomy in the Department of Oral Emergency or the First Clinical Division,Peking University School and Hospital of Stomatology from March 2017 to September 2022 due to complicated crown fracture of anterior teeth,and had taken at least one post-operation apical radiograph were reviewed.The clinical and radiographic information at the initial examination and follow-up period were obtained,including crown color,mobility,percussion,cold test(partial pulpotomy teeth),dental restoration,fistula,swelling or inflammation of the gingival tissue,the formation of apical foramen,pathologic radiolucency and calcification of pulp chamber or root canal obliteration.Data were tested by Fisher exact test and a multiple comparison.Results:In the study,64 patients including 37 males(57.8%)and 27 females(42.2%)with a mean age of 9.1 years were finally enrolled.The total number of permanent teeth that received pulpotomy was 75,and the average follow-up time was 19.3 months.The success rate was 93.1%with the time interval between dental injury and treatment in 24 h,while the success rate dropped to 88.2%with the time intervals beyond 24 h.The time intervals did not significantly affect the pulp survival rate(P=0.61)after pulpotomy(partial or co-ronal).The success rate 6 months after pulpotomy was 96.0%,and one-year success rate was 94.7%.A total of 23 cases were reviewed for more than 2 years after pulpotomy,and 6 cases failed.The mobility had no significant effect on the success rate(P=0.28).Pulp chamber calcification and pulp canal obli-teration were not observed in all the post-operative radiographs.Conclusion:The one year clinical and radiographic success rates obtained in this study indicate that iRoot BP Plus? is an appropriate pulp cap-ping material option for pulpotomy treatment of complicated crown fracture in immature permanent teeth without displacement injuries.This technique has broad promotional value.
4.Effect of a three-tier delirium nursing management process on NICU patients with acute stroke
Canfang SHE ; Xinru HE ; Caihong ZHOU ; Chang HUANG ; Wei ZHU ; Lihui SHAO ; Min FU
Modern Clinical Nursing 2024;23(1):56-62
Objective To investigate the effect of a three-tier delirium care management process in patients with acute stroke in neurology intensive care unit(NICU).Methods A total of 50 patients with acute stroke admitted to the NICU of the Fourth Hospital of Changsha from May to September 2021 were assigned to the control group.The patients in the control group received routine NICU nursing care to prevent delirium.Another 50 patients with acute stroke admitted to the NICU from December 2021 to April 2022 were assigned to the trial group.They were managed with the three-tier delirium nursing management process on top of the routine NICU nursing care for the control group.The incidence of ICU delirium(DICU),duration of DICU,length of stay in NICU and the incidence of delirium-related adverse events were compared between the two groups.The degree of delirium and cognitive function before and after the intervention were compared between the two groups as well.Results The trial group had significantly shorter duration of DICU and NICU stay(both P<0.05)and lower incidence rate of delirium-related adverse events(P<0.05)compared to the control group.After the intervention,the trial group showed significantly lower scores on the intensive care delirium screening checklist(ICDSC)and significantly higher scores of cognitive function compared to those of the control group(both P<0.05).Conclusion The three-tier delirium nursing management process can lower the occurrence of delirium in NICU patients with acute stroke,shorten the NICU stay,reduce the safety risk in nursing,and improve the cognitive function.
5.Clinical application and progress of yttrium 90 microsphere selective internal radiation therapy in primary hepatic cancer
Hui ZHANG ; Ying FU ; Binbin TAN ; Minghua SHAO ; Ping LIU ; Chao FAN ; Hailei CHEN ; Zhiyu CHEN
Chinese Journal of Digestive Surgery 2024;23(2):242-247
Primary hepatic cancer is one of the major problems that need to be solved urgently in the field of public health, seriously endangering the life and health of Chinese people. Its treatment mode is multidisciplinary participation and synergy of multiple therapeutic methods. Even though there are many common clinical treatments for liver cancer in China, its therapeutic outcome is still unsatisfactory. yttrium-90 has been applied for more than 20 years, and a large amount of foreign clinical data have been accumulated. Combining the latest literature and clinical practice, the authors describe the clinical application and research progress of yttrium-90 micro-sphere selective internal radiation therapy in primary liver cancer.
6.Multi-criteria decision analysis of four first-line combination immunotherapy for unresectable hepatocellular carcinoma
Rongrong ZHANG ; Yu FU ; Ruixia ZHAO ; Yuxuan FANG ; Jingwen WANG ; Mingyi SHAO
China Pharmacy 2024;35(15):1876-1881
OBJECTIVE To evaluate the comprehensive value of four first-line combination immunotherapy for unresectable hepatocellular carcinoma, and provide a reference for determining the optimal clinical treatment decision for unresectable hepatocellular carcinoma. METHODS R4.2 software was used for network meta-analysis to obtain the effect values of the efficacy and safety indicators of four combination therapies [atezolizumab combined with bevacizumab (AB), sintilimab combined with bevacizumab biosimilars (SB), camrelizumab combined with apatinib (CA), durvalumab combined with tremelimumab (DT)]. Combined with the efficacy, safety and economic indicators, the categorical based evaluation technique (M-MACBETH) was used to establish the value tree. At the same time, the comprehensive value scores of four therapies were calculated, and sensitivity analysis was performed to evaluate the robustness. RESULTS In terms of prolonging median overall survival, the advantage order of the four therapies was ranked as SB, CA, AB and DT. In terms of extending median progression-free survival, the advantage order of the four therapies was CA, SB, AB and DT. In terms of safety, the order of advantages was DT, AB, SB and CA. In terms of economy, the order of advantages was CA, SB, AB and DT. The comprehensive scores of SB, CA, AB and DT were 67.11, 57.77, 52.53 and 42.59 points, respectively. The results of the sensitivity analysis showed that the ranking results of comprehensive value for four regimens were robust. CONCLUSIONS Among the four first-line immune combination therapies for unresectable hepatocellular carcinoma, SB is the optimal treatment regimen, followed by CA, AB and DT.
7.Effects of Natural Moxibustion at "Feishu (BL 13)" on Th17/Treg Immune Balance and Inflammatory Response in Healthy Rats
Jia LIN ; Xiaomei SHAO ; Ruiyang FU ; Jinxia LI ; Xiaoqing GUO
Journal of Traditional Chinese Medicine 2024;65(16):1703-1708
ObjectiveTo observe the effect of natural moxibustion at "Feishu (BL 13)" on immune balance of T helper cell 17 (Th17) / regulatory T cell (Treg) in healthy rats. MethodsForty-eight rats were randomly divided into 10 rats in the sham moxibustion group and 38 rats in natural moxibustion group. The rats in the sham moxibustion group applied blank acupoint stickers to bilateral "Feishu (BL 13)", and the rats in natural moxibustion group applied acupoint stickers filled with Compound Banmao Ointment (复方斑蝥膏) to bilateral "Feishu (BL 13)" for a period of 8 h. Thirty rats in natural moxibustion group were successfully blistered after 8 h, and then were randomly divided into 1-day, 3-day and 7-day groups with 10 rats in each group. The general condition of rats was recorded during the experiment; different time groups of natural moxibustion were sampled at the corresponding time, and HE staining was used to observe the pathological changes of the skin in the area of application; flow cytometry was used to detect the subpopulations of Th17 and Treg in peripheral blood, and the value of Th17/Treg was calculated; and ELISA was used to detect the serum interleukin 17A (IL-17A) and interleukin 6 (IL-6), interleukin 10 (IL-10) levels. ResultsCompared with sham moxibustion group, blisters can be seen in the application area of rats in 1-day natural moxibustion group, and the rats often scratched the skin of the moxibustion area, which showed loose stratum corneum, thickening of the stratum spinosum and stratum granulosum, absence of cells in the basal layer, inflammatory cell infiltration, and elevation of Treg in peripheral blood, and serum IL-17A, IL-6; in 3-day natural moxibustion group, the moxibustion area of the rats was scabbed and partially detached, with the most obvious dermatopathological changes, and elevated peripheral blood Th17 and Treg, and serum IL-17A, IL-6, IL-10; in 7-day natural moxibustion group, skin damage and pathological changes in the area of moxibustion were basically restored; Th17/Treg values were reduced in 1-, 3- and 7-day moxibustion groups after blistering (P<0.05 or P<0.01). Compared with the 1-day moxibustion group, peripheral blood Th17, Treg, and serum IL-17A elevated in the 3-day moxibustion group; peripheral blood Treg, serum IL-17A, and IL-6 decreased, and Th17/Treg values elevated in the 7-day moxibustion group (P<0.05 or P<0.01). Compared with the 3-day moxibustion group, the 7-day moxibustion group had lower peripheral blood Th17 and Treg, serum IL-17A, IL-6, and IL-10, and higher Th17/Treg values (P<0.05 or P<0.01). ConclusionNatural moxibustion at "Feishu (BL 13)" can shift the Th17/Treg balance towards Treg of healthy rats, which will gradually lead to immune homeostasis, and regulate the relevant inflammatory factors in the serum to prevent inflammation from occurring and developing.
8.Clinical trial of Morinda officinalis oligosaccharides in the continuation treatment of adults with mild and moderate depression
Shu-Zhe ZHOU ; Zu-Cheng HAN ; Xiu-Zhen WANG ; Yan-Qing CHEN ; Ya-Ling HU ; Xue-Qin YU ; Bin-Hong WANG ; Guo-Zhen FAN ; Hong SANG ; Ying HAI ; Zhi-Jie JIA ; Zhan-Min WANG ; Yan WEI ; Jian-Guo ZHU ; Xue-Qin SONG ; Zhi-Dong LIU ; Li KUANG ; Hong-Ming WANG ; Feng TIAN ; Yu-Xin LI ; Ling ZHANG ; Hai LIN ; Bin WU ; Chao-Ying WANG ; Chang LIU ; Jia-Fan SUN ; Shao-Xiao YAN ; Jun LIU ; Shou-Fu XIE ; Mao-Sheng FANG ; Wei-Feng MI ; Hong-Yan ZHANG
The Chinese Journal of Clinical Pharmacology 2024;40(6):815-819
Objective To observe the efficacy and safety of Morinda officinalis oligosaccharides in the continuation treatment of mild and moderate depression.Methods An open,single-arm,multi-center design was adopted in our study.Adult patients with mild and moderate depression who had received acute treatment of Morinda officinalis oligosaccharides were enrolled and continue to receive Morinda officinalis oligosaccharides capsules for 24 weeks,the dose remained unchanged during continuation treatment.The remission rate,recurrence rate,recurrence time,and the change from baseline to endpoint of Hamilton Depression Scale(HAMD),Hamilton Anxiety Scale(HAMA),Clinical Global Impression-Severity(CGI-S)and Arizona Sexual Experience Scale(ASEX)were evaluated.The incidence of treatment-related adverse events was reported.Results The scores of HAMD-17 at baseline and after treatment were 6.60±1.87 and 5.85±4.18,scores of HAMA were 6.36±3.02 and 4.93±3.09,scores of CGI-S were 1.49±0.56 and 1.29±0.81,scores of ASEX were 15.92±4.72 and 15.57±5.26,with significant difference(P<0.05).After continuation treatment,the remission rate was 54.59%(202 cases/370 cases),and the recurrence rate was 6.49%(24 cases/370 cases),the recurrence time was(64.67±42.47)days.The incidence of treatment-related adverse events was 15.35%(64 cases/417 cases).Conclusion Morinda officinalis oligosaccharides capsules can be effectively used for the continuation treatment of mild and moderate depression,and are well tolerated and safe.
9.Clinical trial of edaravone and dexborneol combined with rosuvastatin calcium in the treatment of patients with acute posterior circulation cerebral infarction
Tong XU ; Han-Dan SHI ; Lin-Lin SHAO ; Liang-Fu CHEN
The Chinese Journal of Clinical Pharmacology 2024;40(7):949-953
Objective To observe the clinical effect and safety of edaravone and dexborneol concentrated solution for injection combined with rosuvastatin calcium capsules in the treatment of patients with acute posterior circulation cerebral infarction.Methods Patients with acute posterior circulation cerebral infarction were divided into control group and treatment group according to cohort method.The control group was treated with rosuvastatin calcium 5 mg,while the treatment group was treated with intravenous drip of edaravone and dexborneol concentrated solution for injection 15 mL on the basis of control group.The clinical effect,neurological function,biochemical indicators,oxidative stress response indicators,the levels of Toll like receptor 4/nuclear factor κB(TLR4/NF-κB)signaling pathway molecules,prognosis,and adverse drug reactions were compared between the two groups.Results There were 49 cases in control group and 51 cases in treatment group.After treatment,the total effective rates in treatment group and control group were 92.16%(47 cases/51 cases)and 77.55%(38 cases/49 cases),with statistically significant difference(P<0.05).After treatment,the levels of neuron specific enolase in treatment group and control group were(11.67±1.35)and(16.77±1.94)μg·L-1;the levels of central nervous system-specific protein were(1.01±0.12)and(1.54±0.16)μg·L-1;the levels of low density lipoprotein cholesterol were(2.03±0.24)and(3.74±0.38)mmol·L-1;the levels of triglyceride were(1.28±0.14)and(2.12±0.23)mmol·L-1;the levels of total cholesterol were(3.11±0.32)and(4.15±0.42)mmol·L-1;the levels of creatine kinase isozyme were(8.76±1.02)and(10.12±1.06)U·L-1;the levels of high-sensitivity C-reactive protein were(11.01±1.25)and(15.32±1.64)mg·L-1;the levels of serum reactive oxygen species were(387.68±39.24)and(473.11±48.23)μmol·L-1;the levels of malondialdehyde were(3.02±0.39)and(4.14±0.45)nmol·mL-1;the levels of superoxide dismutase were(59.24±6.05)and(41.67±4.97)U·mL-1;the relative expression levels of TLR4 mRNA were 0.26±0.03 and 0.43±0.04;the relative expression levels of NF-KB mRNA were 0.17±0.02 and 0.25±0.03;the modified Rankin scale scores were 2.02±0.29 and 2.94±0.30;the activity of daily living scores were 56.34±5.74 and 45.64±4.69.The above indexes were significantly different between control group and treatment group(all P<0.05).The total incidence of adverse drug reactions in treatment group and control group were 31.37%and 26.53%,with no statistically significant difference between the two groups(P>0.05).Conclusion Edaravone and dexborneol concentrated solution for injection combined with rosuvastatin calcium capsules is effective in the treatment of patients with acute posterior circulation cerebral infarction,and can effectively regulate the patients'neurological function,oxidative stress response,blood lipid levels and TLR4/NF-κB signaling pathway molecules,and significantly improve the prognosis.
10.Effect of reperfusion therapy on differential expression of plasma exosomal miRNAs in patients with acute myocardial infarction
Zhiyong ZHANG ; Binbin SUN ; Lei YAN ; Zhiguang WANG ; Gang FU ; Guo SHAO
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(2):128-131
Objective To observe the effect of coronary reperfusion therapy on the differential ex-pression of plasma exosomal miRNAs in patients with acute myocardial infarction(AMI).Meth-ods Three elderly male AMI patients undergoing coronary reperfusion therapy in our hospital from October to November 2022 were recruited in this study.The venous blood samples were col-lected at admission and 2 and 24 h after recanalization.MiRNA-sequencing was used to screen the differentially expressed miRNAs which were commonly expressed in the plasma exosomes of the 3 patients.Bioinformatics analysis was performed on the target genes,and then the differentially expressed miR-499a-5p was verified by qPCR.Results Compared with the plasma exosomal miRNAs at admission,there were 418 up-regulated and 406 down-regulated miRNAs at 2 h after operation,and 320 up-regulated and 225 down-regulated miRNAs at 24 h after operation(P<0.05);Compared with the miRNAs at 2 h after operation,there were 344 up-regulated and 350 down-regulated ones at 24 h after operation(P<0.05).Kyoto Encyclopedia of Genes and Ge-nomes enrichment analysis showed that the differentially expressed miRNAs were enriched in phosphatidylinositol-3-kinase-protein kinase B,hypoxia-inducible factor 1,and vascular smooth muscle contraction pathways.Gene Ontology analysis indicated that the molecular functions of dif-ferentially expressed miRNA target genes were mainly enriched in protein binding and DNA bind-ing;cellular components were mainly enriched in cell membrane and cytoplasm;and biological processes were mainly enriched in signaling and transcription of DNA templates.The miR-499a-5p level was significantly lower at 2 h postoperatively than at admission[(0.577±0.020)vs(1.000± 0.023),P<0.05],and at 24 h postoperatively than at 2 h postoperatively[(0.068±0.006)vs(0.577±0.020),P<0.05].Conclusion Plasma exosomal miRNAs can be used as a biomarker for early diagnosis of elderly AMI patients and for predicting the efficacy of reperfusion therapy.

Result Analysis
Print
Save
E-mail